Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
Top Cited Papers
Open Access
- 15 February 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 107 (4) , 1454-1458
- https://doi.org/10.1182/blood-2005-07-2628
Abstract
FTY720, a potent immunomodulatory drug in phase 2/3 clinical trials, induces rapid and reversible sequestration of lymphocytes into secondary lymphoid organs, tKeywords
This publication has 16 references indexed in Scilit:
- Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography–tandem mass spectrometryAnalytical Biochemistry, 2005
- Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720Journal of Biological Chemistry, 2004
- FTY720: Sphingosine 1-Phosphate Receptor-1 in the Control of Lymphocyte Egress and Endothelial Barrier FunctionAmerican Journal of Transplantation, 2004
- Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1Nature, 2004
- The immunosuppressant FTY720 down‐regulates sphingosine 1‐phosphate G protein‐coupled receptorsThe FASEB Journal, 2004
- Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine KinasesJournal of Biological Chemistry, 2003
- Phosphorylation and Action of the Immunomodulator FTY720 Inhibits Vascular Endothelial Cell Growth Factor-induced Vascular PermeabilityJournal of Biological Chemistry, 2003
- The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2FEBS Letters, 2003
- The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate ReceptorsJournal of Biological Chemistry, 2002
- Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor AgonistsScience, 2002